MedTrace Logo

Smoking Cessation Via Text Messaging: Feasibility Testing of Stop My Smoking USA

NCT01516632 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 164

Last updated 2016-06-06

Study results available
· View outcomes & findings →

Summary

The investigators developed a text messaging-based smoking cessation program called SMS (Stop My Smoking) USA. It was tailored for the unique needs and smoking habits of young adults. The investigators hypothesized that those in the SMS USA intervention would be significantly more likely to be quit at 6-months compared to the attention-matched control group.

Conditions

  • Smoking Cessation

Interventions

BEHAVIORAL

SMS USA

Intervention participants receive text messages daily pre-and post-quit. Everyone receives messages 14 days prior to the Quit day, and through the day after Quit. Then, participants are 'pathed' to particular messages based upon their self-reported smoking status at Day 2 and Day 7 post quit, respectively. Those who are successful at quitting receive messages aimed at relapse prevention whereas those who have slipped receive messages aimed at getting the person to recommit to quitting and trying again.

Sponsors & Collaborators

  • Michigan State University

    collaborator OTHER

  • The University of Texas Health Science Center, Houston

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • Center for Innovative Public Health Research

    lead OTHER

Principal Investigators

  • Michele Ybarra, MPH PhD · Center for Innovative Public Health Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01516632 on ClinicalTrials.gov